The targeted use of bioregulatory peptides to support tissue-specific repair, immune modulation, and cellular signaling pathways, administered under physician supervision as part of individualized treatment protocols.
Peptides are short chains of amino acids that serve as signaling molecules in the body, regulating a wide range of physiological processes including immune function, tissue repair, inflammation, and cellular communication. Therapeutic peptides are designed to replicate or enhance these natural signaling functions.
At St. George Hospital, peptide therapy is used within the framework of European biological medicine. Specific peptides are selected based on the patient’s diagnosis and treatment goals, and are administered via injection or infusion under medical supervision. This therapy is considered an adjunct to primary treatment protocols rather than a standalone intervention.
Bioregulatory peptides interact with specific receptors on target cells, triggering intracellular signaling cascades. Depending on the peptide used, these signals can promote tissue regeneration, modulate immune cell activity, reduce inflammatory mediator production, or support hormonal balance.
Examples include thymic peptides that support T-cell maturation and immune regulation, organ-specific peptides from European biological medicine traditions, and newer synthetic peptides with defined molecular targets. The choice of peptide, dose, and route of administration is determined by the attending physician based on the patient’s specific clinical needs.
Peptide therapy at St. George Hospital may be considered as a supportive treatment for:
Note: Peptide therapy is an evolving field. At St. George Hospital, peptides are used within established European medical frameworks. Specific therapeutic claims are not made beyond what is supported by the current level of evidence for each individual peptide.
Peptide therapy is individually prescribed based on diagnostic findings. Our physicians will determine whether specific peptide protocols may support your treatment plan.
Peptide therapy is typically administered via subcutaneous injection or slow intravenous infusion. Sessions are brief, usually 15-30 minutes depending on the route and protocol. The treatment is generally well tolerated, with occasional mild injection-site reactions. Treatment courses vary widely depending on the clinical indication and the specific peptides used.
The evidence base for therapeutic peptides varies considerably by compound. Some peptides, such as thymosin alpha-1, have robust clinical trial data and regulatory approval in multiple countries. Others are supported primarily by preclinical research and case series. At St. George Hospital, peptide selection is guided by the available evidence and clinical experience. Safety monitoring includes regular laboratory assessments and clinical follow-up to evaluate both efficacy and tolerability.
Contact our medical team to discuss whether peptide therapy may be a useful component of your treatment plan.
